SEC-sourced researchBeta
CBDY
Target Group Inc.
Company comparison ↗
Data passport
- CIK
- 0001586554
- Exchange
- OTC
- Business activity
- Medicinal Chemicals & Botanical Products · SIC 2833
- Financial inputs
- 6/6
- Filing date
- Nov 16, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 6,591,625.0000 | Mar 31, 2026 |
| December 2025 | 3,881,003.0000 | Mar 31, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 3,881,003.0000 | -1,359,682.0000 | -842,425.0000 | 6,176,749.0000 | 14,239,697.0000 | Mar 31, 2026 |
| December 2024 | 6,591,625.0000 | 160,504.0000 | 2,162,684.0000 | 7,573,533.0000 | 14,081,162.0000 | Mar 31, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
23/100
Profitability0
Growth9
Balance sheet0
Cash generation7
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $3.88M | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $6.59M | Jan 1, 2024 – Dec 31, 2024 | Mar 31, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$1.36M | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$842.43K | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Total assetsAssets | $6.18M | Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Total liabilitiesLiabilities | $14.24M | Dec 31, 2025 | Mar 31, 2026 | 10-K |